Paper42306754
Effectiveness and safety of cryoablation therapy for early-stage lung cancer patients: a systematic review and meta-analysis.
Zhang K and 5 others. J Thorac Dis, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Effectiveness and safety of cryoablation therapy for early-stage lung cancer patients: a systematic review and meta-analysis. Papers, record 42306754. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42306754
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Effectiveness and safety of cryoablation therapy for early-stage lung cancer patients: a systematic review and meta-analysis.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References26
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 21714641 | Reduced lung-cancer mortality with low-dose computed tomographic screening. | N Engl J Med | 2011 | https://conductscience.org/library/papers/21714641 | PubMed |
| 2 | 40262688 | Stereotactic reirradiation for in-field lung cancer recurrence after stereotactic ablative radiotherapy: A systematic review and meta-analysis. | Radiother Oncol | 2025 | https://conductscience.org/library/papers/40262688 | PubMed |
| 3 | 19933688 | A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L). | Jpn J Clin Oncol | 2010 | https://conductscience.org/library/papers/19933688 | PubMed |
| 4 | 40930154 | NCCN Guidelines® Insights: Non-Small Cell Lung Cancer, Version 7.2025. | J Natl Compr Canc Netw | 2025 | https://conductscience.org/library/papers/40930154 | PubMed |
| 5 | 40358802 | Percutaneous cryoablation in the management of spinal metastases: a comprehensive systematic review and meta-analysis. | J Neurooncol | 2025 | https://conductscience.org/library/papers/40358802 | PubMed |
| 6 | 40184836 | Stereotactic body radiation therapy (SBRT) of centrally located medically inoperable early-stage non-small cell lung cancer (T1-T3N0M0) - A subgroup analysis of the expanded HILUS study. | Lung Cancer | 2025 | https://conductscience.org/library/papers/40184836 | PubMed |
| 7 | 30442588 | Perioperative mortality and morbidity after sublobar versus lobar resection for early-stage non-small-cell lung cancer: post-hoc analysis of an international, randomised, phase 3 trial (CALGB/Alliance 140503). | Lancet Respir Med | 2018 | https://conductscience.org/library/papers/30442588 | PubMed |
| 8 | 37527771 | Pulmonary Cryoablation Outcomes in Octogenarians and Nonagenarians with Primary Lung Cancer. | J Vasc Interv Radiol | 2023 | https://conductscience.org/library/papers/37527771 | PubMed |
| 9 | 30964113 | Computed tomography-guided percutaneous cryoablation for lung ground-glass opacity: A pilot study. | J Cancer Res Ther | 2019 | https://conductscience.org/library/papers/30964113 | PubMed |
| 10 | 25735518 | Five-year survival after cryoablation of stage I non-small cell lung cancer in medically inoperable patients. | J Vasc Interv Radiol | 2015 | https://conductscience.org/library/papers/25735518 | PubMed |
| 11 | 40463877 | Cryoablation in the treatment of early breast cancer: a comprehensive analysis. | Front Oncol | 2025 | https://conductscience.org/library/papers/40463877 | PubMed |
| 12 | 40562488 | Cryoablation for Renal Denervation: A Cool Alternative to Thermal Approaches? | JACC Basic Transl Sci | 2025 | https://conductscience.org/library/papers/40562488 | PubMed |
| 13 | 40187813 | Cryoablation in breast tumours. | Radiologia (Engl Ed) | 2025 | https://conductscience.org/library/papers/40187813 | PubMed |
| 14 | 41035665 | Stereotactic body radiation therapy for early-stage non-small cell lung cancer: a single-institutional retrospective analysis of outcomes and prognostic factors. | Front Oncol | 2025 | https://conductscience.org/library/papers/41035665 | PubMed |
| 15 | 25981812 | Stereotactic ablative radiotherapy versus lobectomy for operable stage I non-small-cell lung cancer: a pooled analysis of two randomised trials. | Lancet Oncol | 2015 | https://conductscience.org/library/papers/25981812 | PubMed |
| 16 | 33782057 | The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. | BMJ | 2021 | https://conductscience.org/library/papers/33782057 | PubMed |
| 17 | 37172368 | Outcomes following cryoablation of stage IA non-small cell lung cancer in patients with and without interstitial lung disease: A retrospective single-center cohort study. | Lung Cancer | 2023 | https://conductscience.org/library/papers/37172368 | PubMed |
| 18 | 41453487 | Lung Ablation Outcomes for Inoperable Stage IA Non-Small Cell Lung Cancer. | J Vasc Interv Radiol | 2026 | https://conductscience.org/library/papers/41453487 | PubMed |
| 19 | 33538338 | Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. | CA Cancer J Clin | 2021 | https://conductscience.org/library/papers/33538338 | PubMed |
| 20 | 40223661 | Stereotactic body radiotherapy for central non-small cell lung cancer: risk analysis of radiation pneumonitis and bronchial dose constraints. | J Radiat Res | 2025 | https://conductscience.org/library/papers/40223661 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Cited by
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/42306754
GET https://conductscience.org/api/papers/v1/42306754/references?page=2